Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00798135 · ClinicalTrials.gov registry record · NA
A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00798135 is a NA study that has completed, run by Indiana University. The registered enrollment target is 13 participants.
The verdict
NCT00798135, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
Cancer cells need to be able to make new blood vessels in order to keep growing. This is called angiogenesis. In a laboratory setting, the drug itraconazole was shown to help stop the growth of new blood vessels (anti-angiogenesis). It is hoped that itraconazole will prevent new blood vessels from forming in humans too. The purpose of this study is to look at how the body processes and breaks down itraconazole (called pharmacokinetics). This study will also measure markers in your blood to see if itraconazole stops new blood vessels from forming. The safety of itraconazole will also be tested to see what effects (good and bad) it has on you and your breast cancer.
Interventions
- DRUG itraconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2008-11 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00798135
The ClinicalTrials.gov registry entry for NCT00798135 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which itraconazole is the first listed.
NCT00798135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00798135 about?
NCT00798135 is a clinical study titled "A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer". Cancer cells need to be able to make new blood vessels in order to keep growing. This is called angiogenesis. In a laboratory setting, the drug itraconazole was shown to help stop the growth of new blood vessels (anti-angiogenesis). It is hoped that itraconazole will prevent new blood vessels from f...
What is the current status of trial NCT00798135?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2008-11. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00798135?
The interventions under investigation include: itraconazole (DRUG).
Who is sponsoring clinical trial NCT00798135?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.